|1|Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor. (23695010)
Moretto R.... Palmieri G.
|2|NUT rearrangement is uncommon in human thymic epithelial tumors. (22425924)
Petrini P.... Giaccone G.
|3|Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems. (22974165)
Ma Y.... Wang J.
|4|Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor? (23091442)
Oh D.... Han J.
|5|Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and I^ III-tubulin in thymic epithelial tumors. (21289518)
Kaira K.... Yamamoto N.
|6|MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma. (21253760)
Kaira K.... Yamamoto N.
|7|Expression of proteasome subunit I^5t in thymic epithelial tumors. (21836487)
Yamada Y.... Kasahara M.
|8|Successful diagnosis of a combined thymic epithelial tumor by endobronchial ultrasound-guided transbronchial needle aspiration. (23896935)
Okamoto T.... Inase N.
|9|Heat shock protein 90-sheltered overexpression of insulin-like growth factor 1 receptor contributes to malignancy of thymic epithelial tumors. (21372220)
Breinig M.... Rieker R.J.
|10|Expression and mutational status of c-kit in thymic epithelial tumors. (20651610)
Petrini I.... Giaccone G.
|11|Thymic epithelial tumor with heart metastasis in a horse. (20814442)
Shahriar F.... Moore J.
|12|CD98 expression is associated with the grade of malignancy in thymic epithelial tumors. (20811665)
Kaira K.... Yamamoto N.
|13|Type B3 thymic epithelial tumor in an adolescent detected by immunohistochemical staining for CD5, CD99, and KIT (CD117): a case report. (19901887)
Yoshino N.... Shimizu K.
|14|Computed tomographic findings and prognosis in thymic epithelial tumor patients. (18830115)
Yakushiji S.... Kusumoto M.
|15|Absence of gene mutations in KIT-positive thymic epithelial tumors. (18486988)
Tsuchida M.... Hayashi J.I.
|16|Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. (17762439)
Kundel Y.... Levitt M.L.
|17|Correlation between MMP-2 activation and MT1-MMP mRNA expression in thymic epithelial tumors]. (16608644)
Wang Y.... Wang E.H.
|18|Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors. (16762968)
Suzuki E.... Fujii Y.
|19|Multimodality treatment program in invasive thymic epithelial tumor. (15685027)
Jacot W.... Pujol J.L.
|20|Expression of neurotrophin receptors in surgically resected thymic epithelial tumors. (16125946)
Kim D.J.... Chung K.Y.
|21|Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. (16002927)
Nakagawa K.... Tsuchiya R.
|22|Expression of cyclins D1, D3 and p27 in thymic epithelial tumors. (17670226)
Zisis C.... Bellenis I.
|23|High incidence of thymic epithelial tumors in E2F2 transgenic mice. (14684733)
Scheijen B.... Bernards R.
|24|KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors. (15494865)
Comin C.E.... Dini S.
|25|Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors. (14584061)
Sogawa K.... Monden Y.
|26|Expression of matrix metalloproteinases 2 and 7 in tumor cells correlates with the World Health Organization classification subtype and clinical stage of thymic epithelial tumors. (14691910)
Takahashi E.... Eimoto T.
|27|Apoptosis in thymic epithelial tumors. (12234065)
Park S.H.... Ro J.Y.
|28|Thymic epithelial tumors can develop along two different pathogenetic pathways. (11696445)
Zhou R.... Starostik P.
|29|Activation of matrix metalloproteinase-2 is correlated with invasiveness in thymic epithelial tumors. (11276020)
Kondo K.... Monden Y.
|30|Differential expression of NGF receptors in human thymic epithelial tumors. (10483585)
Parrens M.... Merlio J.P.
|31|Correlation between clinical aggressiveness of thymic epithelial tumors and expression of tumor suppressor gene products (p53, p27)]. (10496046)
Fukiwake N.... Sugimachi K.
|32|Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. (9563781)
Hishima T.... Koike M.
|33|Thymic epithelial tumor progression in an SV40T transgenic mouse model. Cortical thymoma-thymic carcinoma sequence. (9463585)
Lee S.S.... Jang J.J.
|34|p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors. (9852302)
Oyama T.... Yasumoto K.
|35|Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors. (9346177)
Tateyama H.... Takino H.
|36|Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. (9371941)
Voltz R.D.... Hohlfeld R.
|37|p53 protein expression and p53 mutation in thymic epithelial tumors. (8623777)
|38|Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Implications for the pathogenesis of myasthenia gravis. (8669470)
Marx A.... MA1ller-Hermelink H.K.
|39|The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors. (7573670)
Chan J.K.... Pau M.Y.
|40|p53 protein expression and p53 gene mutation in thymic epithelial tumors. An immunohistochemical and DNA sequencing study. (7572785)
Tateyama H.... Masaoka A.
|41|Cytokeratins in normal thymus and thymic epithelial tumors. (7677978)
Fukai I.... Tanamura O.